Point Of Care Diagnostics Market Size, Share & Trends Report

Point Of Care Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End Use (Clinics, Home, Hospitals), By Region, And Segment Forecasts

Market Segmentation

Point Of Care Diagnostics Product Outlook (Revenue in USD Billion, 2018 - 2030)
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
  - HIV POC
  - Clostridium Difficile POC
  - HBV POC
  - Pneumonia or Streptococcus Associated Infections
  - Respiratory Syncytial Virus (RSV) POC
  - HPV POC
  - Influenza/Flu POC
  - HCV POC
  - MRSA POC
  - TB and Drug-resistant TB POC
  - HSV POC
  - COVID-19
  - Other Infectious Diseases
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Autoimmune Diseases
- Urinalysis/Nephrology
Point Of Care Diagnostics End Use Outlook (Revenue in USD Billion, 2018 - 2030)
- Clinics
  - Pharmacy & Retail Clinics
  - Physician Office
  - Urgent Care Clinics
  - Non-practice Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Point Of Care Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Glucose Testing
    - Hb1Ac Testing
    - Coagulation Testing
    - Fertility/Pregnancy
    - Infectious Disease
      - HIV POC
      - Clostridium Difficile POC
      - HBV POC
      - Pneumonia or Streptococcus Associated Infections
      - Respiratory Syncytial Virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and Drug-resistant TB POC
      - HSV POC
      - COVID-19
      - Other Infectious Diseases
    - Cardiac Markers
    - Thyroid Stimulating Hormone
    - Hematology
    - Primary Care Systems
    - Decentralized Clinical Chemistry
    - Feces
    - Lipid Testing
    - Cancer Marker
    - Blood Gas/Electrolytes
    - Ambulatory Chemistry
    - Drug of Abuse (DOA) Testing
    - Autoimmune Diseases
    - Urinalysis/Nephrology
  - North America End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    - Clinics
      - Pharmacy & Retail Clinics
      - Physician Office
      - Urgent Care Clinics
      - Non-practice Clinics
    - Hospitals
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratory
  - U.S.
    - U.S. Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - U.S. End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Canada
    - Canada Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Canada End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Mexico
    - Mexico Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Mexico End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
- Europe
  - Europe Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Glucose Testing
    - Hb1Ac Testing
    - Coagulation Testing
    - Fertility/Pregnancy
    - Infectious Disease
      - HIV POC
      - Clostridium Difficile POC
      - HBV POC
      - Pneumonia or Streptococcus Associated Infections
      - Respiratory Syncytial Virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and Drug-resistant TB POC
      - HSV POC
      - COVID-19
      - Other Infectious Diseases
    - Cardiac Markers
    - Thyroid Stimulating Hormone
    - Hematology
    - Primary Care Systems
    - Decentralized Clinical Chemistry
    - Feces
    - Lipid Testing
    - Cancer Marker
    - Blood Gas/Electrolytes
    - Ambulatory Chemistry
    - Drug of Abuse (DOA) Testing
    - Autoimmune Diseases
    - Urinalysis/Nephrology
  - Europe End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    - Clinics
      - Pharmacy & Retail Clinics
      - Physician Office
      - Urgent Care Clinics
      - Non-practice Clinics
    - Hospitals
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratory
  - Germany
    - Germany Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Germany End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - U.K.
    - U.K. Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - U.K. End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - France
    - France Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - France End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Italy
    - Italy Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Italy End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Spain
    - Spain Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Spain End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Russia
    - Russia Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Russia End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Denmark
    - Denmark Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Denmark End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Sweden
    - Sweden Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Sweden End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Norway
    - Norway Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Norway End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Glucose Testing
    - Hb1Ac Testing
    - Coagulation Testing
    - Fertility/Pregnancy
    - Infectious Disease
      - HIV POC
      - Clostridium Difficile POC
      - HBV POC
      - Pneumonia or Streptococcus Associated Infections
      - Respiratory Syncytial Virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and Drug-resistant TB POC
      - HSV POC
      - COVID-19
      - Other Infectious Diseases
    - Cardiac Markers
    - Thyroid Stimulating Hormone
    - Hematology
    - Primary Care Systems
    - Decentralized Clinical Chemistry
    - Feces
    - Lipid Testing
    - Cancer Marker
    - Blood Gas/Electrolytes
    - Ambulatory Chemistry
    - Drug of Abuse (DOA) Testing
    - Autoimmune Diseases
    - Urinalysis/Nephrology
  - Asia Pacific End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    - Clinics
      - Pharmacy & Retail Clinics
      - Physician Office
      - Urgent Care Clinics
      - Non-practice Clinics
    - Hospitals
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratory
  - Japan
    - Japan Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Japan End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - China
    - China Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - China End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - India
    - India Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - India End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - South Korea
    - South Korea Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - South Korea End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Australia
    - Australia Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Australia End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Thailand
    - Thailand Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Thailand End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
- Latin America
  - Latin America Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Glucose Testing
    - Hb1Ac Testing
    - Coagulation Testing
    - Fertility/Pregnancy
    - Infectious Disease
      - HIV POC
      - Clostridium Difficile POC
      - HBV POC
      - Pneumonia or Streptococcus Associated Infections
      - Respiratory Syncytial Virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and Drug-resistant TB POC
      - HSV POC
      - COVID-19
      - Other Infectious Diseases
    - Cardiac Markers
    - Thyroid Stimulating Hormone
    - Hematology
    - Primary Care Systems
    - Decentralized Clinical Chemistry
    - Feces
    - Lipid Testing
    - Cancer Marker
    - Blood Gas/Electrolytes
    - Ambulatory Chemistry
    - Drug of Abuse (DOA) Testing
    - Autoimmune Diseases
    - Urinalysis/Nephrology
  - Latin America End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    - Clinics
      - Pharmacy & Retail Clinics
      - Physician Office
      - Urgent Care Clinics
      - Non-practice Clinics
    - Hospitals
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratory
  - Brazil
    - Brazil Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Brazil End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Argentina
    - Argentina Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Argentina End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
- Middle East and Africa (MEA)
  - MEA Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Glucose Testing
    - Hb1Ac Testing
    - Coagulation Testing
    - Fertility/Pregnancy
    - Infectious Disease
      - HIV POC
      - Clostridium Difficile POC
      - HBV POC
      - Pneumonia or Streptococcus Associated Infections
      - Respiratory Syncytial Virus (RSV) POC
      - HPV POC
      - Influenza/Flu POC
      - HCV POC
      - MRSA POC
      - TB and Drug-resistant TB POC
      - HSV POC
      - COVID-19
      - Other Infectious Diseases
    - Cardiac Markers
    - Thyroid Stimulating Hormone
    - Hematology
    - Primary Care Systems
    - Decentralized Clinical Chemistry
    - Feces
    - Lipid Testing
    - Cancer Marker
    - Blood Gas/Electrolytes
    - Ambulatory Chemistry
    - Drug of Abuse (DOA) Testing
    - Autoimmune Diseases
    - Urinalysis/Nephrology
  - MEA End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    - Clinics
      - Pharmacy & Retail Clinics
      - Physician Office
      - Urgent Care Clinics
      - Non-practice Clinics
    - Hospitals
    - Home
    - Assisted Living Healthcare Facilities
    - Laboratory
  - South Africa
    - South Africa Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - South Africa End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue in USD Billion, 2018 - 2030)
    - Saudi Arabia End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - UAE
    - UAE Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - UAE End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory
  - Kuwait
    - Kuwait Product Outlook (Revenue in USD Billion, 2018 - 2030)
      - Glucose Testing
      - Hb1Ac Testing
      - Coagulation Testing
      - Fertility/Pregnancy
      - Infectious Disease
        
        HIV POC
        
        Clostridium Difficile POC
        
        HBV POC
        
        Pneumonia or Streptococcus Associated Infections
        
        Respiratory Syncytial Virus (RSV) POC
        
        HPV POC
        
        Influenza/Flu POC
        
        HCV POC
        
        MRSA POC
        
        TB and Drug-resistant TB POC
        
        HSV POC
        
        COVID-19
        
        Other Infectious Diseases
      - Cardiac Markers
      - Thyroid Stimulating Hormone
      - Hematology
      - Primary Care Systems
      - Decentralized Clinical Chemistry
      - Feces
      - Lipid Testing
      - Cancer Marker
      - Blood Gas/Electrolytes
      - Ambulatory Chemistry
      - Drug of Abuse (DOA) Testing
      - Autoimmune Diseases
      - Urinalysis/Nephrology
    - Kuwait End Use Outlook (Revenue in USD Billion, 2018 - 2030)
      - Clinics
        
        Pharmacy & Retail Clinics
        
        Physician Office
        
        Urgent Care Clinics
        
        Non-practice Clinics
      - Hospitals
      - Home
      - Assisted Living Healthcare Facilities
      - Laboratory

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments